S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.21%) $0.928
USD/NOK
(0.35%) $10.88
USD/GBP
(0.00%) $0.792
USD/RUB
(-0.30%) $92.30

Realtime updates for Theranexus SA [ALTHX.PA]

Exchange: EURONEXT Industry: Biotechnology
Last Updated28 Mar 2024 @ 12:35

-2.37% 1.152

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:35):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders...

Stats
Today's Volume 19 621.00
Average Volume 34 291.00
Market Cap 8.88M
EPS €0 ( 2024-01-17 )
Next earnings date ( €0 ) 2024-04-11
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -0.990
ATR14 €0.0270 (2.35%)

Volume Correlation

Long: 0.05 (neutral)
Short: 0.09 (neutral)
Signal:(52.458) Neutral

Theranexus SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Theranexus SA Correlation - Currency/Commodity

The country flag -0.83
( strong negative )
The country flag -0.78
( moderate negative )
The country flag 0.00
( neutral )
The country flag -0.63
( weak negative )
The country flag 0.18
( neutral )
The country flag 0.74
( moderate )

Theranexus SA Financials

Annual 2022
Revenue: €414 898
Gross Profit: €82 898.00 (19.98 %)
EPS: €-1.240
Q2 2023
Revenue: €244 331
Gross Profit: €76 331.00 (31.24 %)
EPS: €-0.680
Q4 2022
Revenue: €2 245.00
Gross Profit: €-163 755 (-7 294.21 %)
EPS: €-0.610
Q2 2022
Revenue: €412 653
Gross Profit: €246 653 (59.77 %)
EPS: €-0.620

Financial Reports:

No articles found.

Theranexus SA

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators